In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her-2/neu binding sites.
about
Engineered IgG1-Fc--one fragment to bind them allFc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds.Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.Engineered Soluble Monomeric IgG1 Fc with Significantly Decreased Non-Specific Binding.
P2860
In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her-2/neu binding sites.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
In vivo and in vitro activity ...... eered Her-2/neu binding sites.
@en
type
label
In vivo and in vitro activity ...... eered Her-2/neu binding sites.
@en
prefLabel
In vivo and in vitro activity ...... eered Her-2/neu binding sites.
@en
P2093
P2860
P356
P1476
In vivo and in vitro activity ...... neered Her-2/neu binding sites
@en
P2093
Bernhard Antes
Florian Rüker
Geert C Mudde
Kevin Moulder
Manuela Kainer
Max Woisetschläger
Radha Borrowdale
Susanne Wiederkum
P2860
P304
P356
10.1002/BIOT.201300387
P577
2014-05-08T00:00:00Z